Medmira (TSE:MIR) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MedMira Inc. has received approval from Health Canada for its Multiplo Rapid TP/HIV Test, a crucial tool for addressing the health crises of HIV and syphilis in Canada. This rapid test, which provides immediate results using a simple finger prick, is expected to significantly impact the healthcare system by offering a fast and cost-effective screening method.
For further insights into TSE:MIR stock, check out TipRanks’ Stock Analysis page.